MELODEA LTD

Their core work

Melodea is an Israeli SME specializing in nanocellulose-based materials and bio-based product development. They develop sustainable alternatives to petroleum-based materials, with applications ranging from food packaging (bioplastics like PHA/PHBV) to printed electronics and biosensing platforms built on nanocellulose substrates. Their consistent participation in Innovation Actions indicates they operate at the pilot-line and prototyping stage, bridging lab-scale bio-material research with industrial manufacturing. They bring nanocellulose expertise into diverse product contexts — packaging, sensors, construction materials, and composites.

What they specialise in

How they've shifted over time

Melodea's early H2020 work (2017–2019) centered on sustainable food packaging, bioplastics (PHA/PHBV), and nanocellulose-based biosensors — applying bio-materials to specific end products. From 2021 onward, their focus shifted toward nano-enabled material testing infrastructure, inline monitoring, and standardization through pilot lines (BIOMAT). This evolution suggests a move from being a material developer embedded in product-specific projects to positioning themselves within open innovation test beds that serve multiple industries.

Melodea is transitioning from niche bio-material applications toward scalable, standardized nano-material manufacturing — making them increasingly relevant for any consortium needing pilot-line capacity for bio-based composites.

How they like to work

Melodea operates exclusively as a consortium participant, never leading projects — typical for a specialized SME contributing deep technical know-how rather than managing large partnerships. With 70 unique partners across 18 countries from just 4 projects, they integrate into large, diverse consortia (averaging ~18 partners per project). This breadth signals adaptability and a reputation as a reliable technical contributor that larger coordinators actively recruit.

Despite being an Israeli SME, Melodea has built a remarkably wide European network — 70 unique partners across 18 countries through just 4 projects. Their reach is pan-European with no obvious geographic clustering, reflecting their participation in large Innovation Action consortia.

What sets them apart

Melodea occupies a rare niche as a nanocellulose-focused SME that can contribute to both food/packaging and advanced manufacturing consortia. Their Israeli base gives them access to a strong deeptech ecosystem (Rehovot is home to the Weizmann Institute), while their H2020 track record demonstrates proven ability to work within large European consortia. For consortium builders, they offer specialized bio-material and nanocellulose expertise combined with pilot-line experience — a combination few SMEs can match.

Highlights from their portfolio

• GREENSENSE
  Largest single grant (EUR 741K) and most technically ambitious — combining nanocellulose, printed electronics, NFC, and biosensing into a wireless drug-detection platform.
• BIOMAT
  Most recent project (2021–2024) and signals strategic shift toward open innovation test beds and standardized nano-material pilot lines.
• YPACK
  Earliest project, directly addressing food waste through bioplastic packaging — represents Melodea's foundational expertise in sustainable bio-materials.